Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes

Experimental Neurology

Volumn 225, Issue 2, 2010, Pages 341-352

  Walker, Peter A ^a   Shah, Shinil K ^a,b   Jimenez, Fernando ^a   Gerber, Michael H ^a   Xue, Hasen ^a   Cutrone, Rochelle ^c   Hamilton, Jason A ^c   Mays, Robert W ^c   Deans, Robert ^c   Pati, Shibani ^a   Dash, Pramod K ^a   Cox, Charles S ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c ATHERSYS INC   (United States)

Author keywords

Blood brain barrier; Multipotent adult progenitor cells; Splenocytes; Stem cells; Traumatic brain injury

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; OCCLUDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN PROTECTION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL INTERACTION; CELL STIMULATION; CELL VOLUME; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANE PERMEABILITY; MICROVASCULATURE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY; ADULT STEM CELL; ANALYSIS OF VARIANCE; ANIMAL; BRAIN INJURIES; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; ORGAN SIZE; PATHOLOGY; PERMEABILITY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ADULT STEM CELLS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTERLEUKIN-10; INTERLEUKIN-4; MALE; ORGAN SIZE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; STEM CELL TRANSPLANTATION;

EID: 77956433599     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.07.005     Document Type: Article

References (25)

1. Ajmo C.T., Collier L.A., Leonardo C.C., Hall A.A., Green S.M., Womble T.A., Cuevas J., Willing A.E., Pennypacker K.R. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp. Neurol. 2009, 218:47-55.
2. Boozer S.L.N., Lakshmipathy U., Love B., Raber A., Maitra A., Deans R., Rao M.S., Ting A.E. Global characterization and genomic stability of human multistem, A multipotent adult progenitor cell. J. Stem Cells 2009, 4:17-28.
3. Castro R.F., Jackson K.A., Goodell M.A., Robertson C.S., Liu H., Shine H.D. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002, 297:1299.
4. Cotton B.A., Snodgrass K.B., Fleming S.B., Carpenter R.O., Kemp C.D., Arbogast P.G., Morris J.A. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J. Trauma 2007, 62:26-33. discussion 33-25.
5. Deng J., Petersen B.E., Steindler D.A., Jorgensen M.L., Laywell E.D. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006, 24:1054-1064.
6. English D., Klasko S.K., Sanberg P.R. Elusive mechanisms of "stem cell"-mediated repair of cerebral damage. Exp. Neurol. 2006, 199:10-15.
7. Faul M., Wald M.M., Rutland-Brown W., Sullivent E.E., Sattin R.W. Using a cost-benefit analysis to estimate outcomes of a clinical treatment guideline: testing the Brain Trauma Foundation guidelines for the treatment of severe traumatic brain injury. J. Trauma 2007, 63:1271-1278.
8. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009, 18:683-692.
9. Harting M.T., Jimenez F., Adams S.D., Mercer D.W., Cox C.S. Acute, regional inflammatory response after traumatic brain injury: implications for cellular therapy. Surgery 2008, 144:803-813.
10. Harting M.T., Jimenez F., Cox C.S. The pulmonary first-pass effect, xenotransplantation and translation to clinical trials-a commentary. Brain 2008, 131:e100. author reply e101.
11. Harting M.T., Jimenez F., Xue H., Fischer U.M., Baumgartner J., Dash P.K., Cox C.S. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg. 2009, 110:1189-1197.
12. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 2002, 30:896-904.
13. Liao W., Xie J., Zhong J., Liu Y., Du L., Zhou B., Xu J., Liu P., Yang S., Wang J., Han Z., Han Z.C. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009, 87:350-359.
14. Lighthall J.W. Controlled cortical impact: a new experimental brain injury model. J. Neurotrauma 1988, 5:1-15.
15. Lim J.H., Byeon Y.E., Ryu H.H., Jeong Y.H., Lee Y.W., Kim W.H., Kang K.S., Kweon O.K. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J. Vet. Sci. 2007, 8:275-282.
16. Offner H., Subramanian S., Parker S.M., Afentoulis M.E., Vandenbark A.A., Hurn P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006, 26:654-665.
17. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 2006, 176:6523-6531.
18. Pati, S., Khakoo, A. Y., Zhao, J., Jimenez, F., Gerber, M., Harting, M. T., Redell, J. B., Grill, R. J., Matsuo, Y., Guha, S., Cox, C. S., Reitz, M. S., Holcomb, J. B., Dash, P. K., in press. Human mesenchymal stem cells inhibit vascular permeability by modulating VE-cadherin/beta-catenin signaling. Stem Cells Dev. (Electronic publication ahead of print).
19. Qu C., Mahmood A., Lu D., Goussev A., Xiong Y., Chopp M. Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res. 2008, 1208:234-239.
20. Schrepfer S., Deuse T., Reichenspurner H., Fischbein M.P., Robbins R.C., Pelletier M.P. Stem cell transplantation: the lung barrier. Transplant. Proc. 2007, 39:573-576.
21. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999, 14:602-615.
22. Unknown Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. JAMA 1999, 282:974-983.
23. Vendrame M., Gemma C., Pennypacker K.R., Bickford P.C., Davis Sanberg C., Sanberg P.R., Willing A.E. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 2006, 199:191-200.
24. Walker P.A., Shah S.K., Harting M.T., Cox C.S. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech. 2009, 2:23-38.
25. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 2002, 174:11-20.